The Institute of Cancer Research

Cancer cell
#Breast cancer #Cancer drug targets #Oncology #The Institute of Cancer Research

Breast cancer study uncovers potential new drug target

Scientists have uncovered a previously unknown mechanism that helps breast cancer cells survive the intense stresses of being malignant, revealing a promising new target for future cancer therapies.  A new study has shown that breast cancer cells become highly dependent on a cell membrane protein called GPR89… Read More

#Cancer Research #Editor's Choice #News

Colorectal cancer
#Colorectal cancer #Oncology #Phase I trial #The Institute of Cancer Research

Targeted therapy shows promise in advanced colorectal cancer

A targeted antibody therapy combined with standard chemotherapy has shown early signs of tumour shrinkage and disease control in patients with advanced bowel cancer.  This is according to new Phase I clinical trial results from The Institute of Cancer Research, London and The Royal Marsden NHS Foundation… Read More

#Cancer Research #Editor's Choice #News

Water molecules
#Cancer research #Computational chemistry #Oncology #The Institute of Cancer Research

Study reveals how water influences cancer drug potency

Researchers have demonstrated how computational simulations can unravel the complex role of water molecules in drug binding.  The study focused on B-cell lymphoma 6 (BCL6), a protein implicated in several cancers. Using advanced computational techniques, the team showed how subtle changes in drug molecules can disrupt or… Read More

#Cancer Research #Editor's Choice #News

Vaccine research
#Cancer drug targets #Oncology #Proteomics #The Institute of Cancer Research

Redox proteomics reveals potential target for cancer therapies

Researchers have discovered that a subtle chemical change to protein p21 acts as a master regulator of cell division – a finding that could influence future cancer therapies.  The study was launched at the Biotechnology Center (BIOTEC) of TUD Dresden University of Technology in Germany and later… Read More

#Cancer Research #Editor's Choice #News

Hepatitis virus
#Oncology #Oncolytic virus #Personalised medicine #The Institute of Cancer Research #Virology

Combining viruses with targeted cancer drugs boosts response

Two studies have uncovered how combining a reovirus with targeted cancer drugs can dramatically boost immune responses and tumour destruction – offering a promising route to more effective, personalised cancer therapies.  Researchers at The Institute of Cancer Research, London, have shown that this combination involving virotherapy can… Read More

#Cancer Research #Editor's Choice #News

X-ray showing colon cancer
#Bowel cancer #Drug resistance #Oncology #Organoids #The Institute of Cancer Research

Scientists uncover mechanism behind drug resistance in bowel cancer

Scientists at The Institute of Cancer Research (ICR), London, have discovered what may cause some treatments to stop working in people living with bowel cancer.   The findings could help researchers use information about a person’s cancer to make better use of current treatments and develop more targeted… Read More

#Cancer Research #News

#Combination therapy #Haematology #Lymphoma #Oncology #The Institute of Cancer Research

Drug combination treats B-cell lymphoma

Research published in the journal Blood shows that the drug tazemetostat could work better when combined with another targeted drug.   For patients with follicular lymphoma, treatment can include the drug tazemetostat – but patients have varying responses, and some see their cancer… Read More

#Cancer Research #Editor's Choice #News

Breast cancer
#ASCO #AstraZeneca #Breast cancer #Oncology #The Institute of Cancer Research

Camizestrant reduces risk of breast cancer progression by 56%

Results of a global study presented at the American Society of Clinical Oncology (ASCO) annual meeting have shown that camizestrant for advanced breast cancer can be used to treat emerging tumours.  The study was funded by AstraZeneca and co-led by researchers at The Institute of Cancer Research,… Read More

#Cancer Research #News #Trending News

Blushwood tree
#Head and neck cancer #Oncology #Plant-based #QBiotics #Solid tumours #The Institute of Cancer Research

Could a molecule from a rainforest tree treat solid tumour cancers?

Scientists at The Institute of Cancer Research, London, are collaborating with life sciences company QBiotics to understand the molecular and cellular mechanisms of a potential new cancer drug.  The collaborative team will study the effects of tigilanol tiglate – a naturally occurring small molecule derived from the… Read More

#Cancer Research #Editor's Choice #News

Institute of Cancer Research
#ATR inhibitors #Genetics / genomics #Oncology #The Institute of Cancer Research

Genetic study predicts success of ATR inhibitors in rare cancer

Scientists at The Institute of Cancer Research, London, have identified a gene that affects how ovarian clear cell carcinoma (OCCC) could respond to a new class of drug called ATR inhibitors.  In clinical trials, ATR inhibitors have demonstrated efficacy as a treatment for various types of cancer,… Read More

#Cancer Research #Editor's Choice #News

#Cancer Research UK #Gene mutation #Genetics / genomics #Oncology #Paediatrics #The Institute of Cancer Research

International team unlocks the genetic secrets of neuroblastoma

A team of international researchers have secured £1.5 ($1.9) million funding from Cancer Research UK (CRUK) to study the genetic secrets of childhood cancer neuroblastoma.  The project will be led by scientists at the University of Sheffield, alongside colleagues from The Institute of Cancer Research (ICR), Kings… Read More

#Cancer Research #News #Trending News

Pancreatic cancer
#Cancer drug targets #Gene mutation #Oncology #The Institute of Cancer Research

Algorithm identifies new potential targets for cancer drugs

Scientists have developed a tool which helps them better understand cancer’s survival tactics and could eventually lead to new treatments for dozens of cancers.  ‘Synthetic lethality’, the tactic of blocking pathways that cancer cells rely on, has so far mainly been successful in patients with BRCA-mutated breast,… Read More

#Cancer Research #News #Trending News

CRISPR Cas9
#Brain cancer #CRISPR #CRISPR screening #Oncology #The Institute of Cancer Research

CRISPR reveals new therapeutic target for glioblastoma

Scientists have shown for the first time that some of the most persistent cancer cells in glioblastoma rely on transforming growth factor beta-activated kinase 1 (TAK1) for survival and that inhibiting this enzyme leads to the death of the cells.  Furthermore, they have demonstrated that it is… Read More

#Cancer Research #News #Trending News